Table 1 Characteristics for the total group and men with or without lifetime history of mood disorder and anxiety disorder
From: Physical comorbidities in men with mood and anxiety disorders: a population-based study
| Â | Â | Mood disorder | Anxiety disorder | |||||
|---|---|---|---|---|---|---|---|---|
Total | Yes | No | P | Yes | No | P | ||
Number = 942 | Number = 160 | Number = 782 | Â | Number = 60 | Number = 882 | Â | ||
Age at interview (years) | 59.3 (45.7, 73.2) | 52.8 (42.6, 64.4) | 60.9 (46.9, 75.4) | <0.001 | 56.2 (41.1, 64.3) | 59.9 (46.0, 74.0) | 0.013 | |
Body mass index (kg/m2) | 27.1 (24.7, 29.6) | 27.1 (24.6, 29.6) | 27.1 (24.8, 29.8) | 0.671 | 27.7 (25.1, 30.3) | 27.1 (24.6, 29.6) | 0.257 | |
Socioeconomic status (IRSAD) | Quintile 1 (most disadvantaged) | 153 (16.2%) | 24 (15.0%) | 129 (16.5%) | 0.581 | 6 (10.0%) | 147 (16.7%) | 0.147 |
Quintile 2 | 189 (20.1%) | 27 (16.9%) | 162 (20.7%) | 12 (20.0%) | 177 (20.1%) | |||
Quintile 3 | 182 (19.3%) | 29 (18.1%) | 153 (19.6%) | 8 (13.3%) | 174 (19.7%) | |||
Quintile 4 | 202 (21.4%) | 37 (23.1%) | 165 (21.1%) | 13 (21.7%) | 189 (21.4%) | |||
Quintile 5 | 216 (22.9%) | 43 (26.9%) | 173 (22.1%) | 21 (35.0%) | 195 (22.1%) | |||
Physically active | 674 (71.9%) | 108 (67.5%) | 566 (72.8%) | 0.179 | 46 (76.7%) | 628 (71.5%) | 0.392 | |
Smokers (current) | 105 (11.2%) | 23 (14.5%) | 82 (10.5%) | 0.153 | 10 (16.7%) | 95 (10.8%) | 0.166 | |
Alcohol consumption (g/day) | 12.4 (2.2, 28.8) | 17.3 (2.0, 34.3) | 11.9 (2.2, 28.3) | 0.156 | 20.3 (2.8, 28.7) | 12.0 (2.8, 28.7) | 0.179 | |
Musculoskeletal disease | 706 (77.0%) | 123 (79.4%) | 583 (76.5%) | 0.443 | 47 (79.7%) | 659 (76.8%) | 0.614 | |
Thyroid disorders | 21 (2.2%) | 4 (2.5%) | 17 (2.2%) | 0.799 | 4 (6.7%) | 17 (1.9%) | 0.016 | |
Metabolic risk factors | 665 (74.3%) | 107 (72.8%) | 558 (74.6%) | 0.646 | 46 (79.3%) | 619 (74.0%) | 0.367 | |
GORD | 124 (13.2%) | 29 (18.1%) | 95 (12.1%) | 0.042 | 16 (26.7%) | 108 (12.2%) | 0.001 | |
Gastrointestinal disorders | 164 (17.4%) | 31 (19.4%) | 133 (17.0%) | 0.472 | 16 (26.7%) | 148 (16.8%) | 0.051 | |
Recurrent headaches | 50 (5.3%) | 15 (9.4%) | 35 (4.5%) | 0.012 | 2 (3.3%) | 48 (5.4%) | 0.481 | |
Syncope and seizures | 157 (16.7%) | 37 (23.1%) | 120 (15.4%) | 0.016 | 12 (20.0%) | 145 (16.4%) | 0.474 | |
Cardiovascular disease | 598 (68.5%) | 91 (65.5%) | 507 (69.1%) | 0.401 | 34 (63.0%) | 564 (68.9%) | 0.366 | |
Pulmonary disease | All | 178 (18.9%) | - | - | Â | 11 (18.3%) | 167 (18.9%) | 0.908 |
<60 years old | 90/478 (18.8%) | 19/109 (17.4%) | 71/369 (19.2%) | 0.671 | - | - | - | |
≥60 years old | 88/464 (19.0%) | 18/51 (35.3%) | 70/416 (17%) | 0.002 | - | - | - | |
Liver disorders | 55 (5.8%) | 16 (10%) | 39 (5%) | 0.014 | 3 (5.0%) | 52 (5.9%) | 0.775 | |
Cancer | 162 (17.2%) | 20 (12.5%) | 142 (18.2%) | 0.084 | 8 (13.3%) | 154 (17.5%) | 0.412 | |
Psoriasis | 41 (4.3%) | 9 (5.6%) | 32 (4.1%) | 0.387 | 5 (8.3%) | 36 (4.1%) | 0.118 | |
High medical burden | 548 (62.2%) | 90 (62.9%) | 458 (62.1%) | 0.843 | 40 (70.2%) | 508 (61.7%) | 0.199 | |